These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36283618)

  • 1. Targeting small heat shock proteins to degrade aggregates as a potential strategy in neurodegenerative diseases.
    Lei T; Xiao Z; Bi W; Cai S; Yang Y; Du H
    Ageing Res Rev; 2022 Dec; 82():101769. PubMed ID: 36283618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle-associated small heat shock proteins as therapeutic agents in neurodegenerative diseases and beyond.
    Van den Broek B; Wuyts C; Irobi J
    Adv Drug Deliv Rev; 2021 Dec; 179():114009. PubMed ID: 34673130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Small Heat Shock Proteins (HspBs) in Alzheimer's and Other Neurological Diseases.
    Golenhofen N; Bartelt-Kirbach B
    Curr Pharm Des; 2016; 22(26):4050-62. PubMed ID: 27194440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The family of mammalian small heat shock proteins (HSPBs): implications in protein deposit diseases and motor neuropathies.
    Boncoraglio A; Minoia M; Carra S
    Int J Biochem Cell Biol; 2012 Oct; 44(10):1657-69. PubMed ID: 22484489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.
    Vos MJ; Zijlstra MP; Kanon B; van Waarde-Verhagen MA; Brunt ER; Oosterveld-Hut HM; Carra S; Sibon OC; Kampinga HH
    Hum Mol Genet; 2010 Dec; 19(23):4677-93. PubMed ID: 20843828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative Disease-Associated TDP-43 Fragments Are Extracellularly Secreted with CASA Complex Proteins.
    Casarotto E; Sproviero D; Corridori E; Gagliani MC; Cozzi M; Chierichetti M; Cristofani R; Ferrari V; Galbiati M; Mina F; Piccolella M; Rusmini P; Tedesco B; Gagliardi S; Cortese K; Cereda C; Poletti A; Crippa V
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential application of heat shock proteins as therapeutic targets in Parkinson's disease.
    Guo H; Yi J; Wang F; Lei T; Du H
    Neurochem Int; 2023 Jan; 162():105453. PubMed ID: 36402293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSF1 and Its Role in Huntington's Disease Pathology.
    Kim H; Gomez-Pastor R
    Adv Exp Med Biol; 2023; 1410():35-95. PubMed ID: 36396925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small heat shock proteins--role in apoptosis, cancerogenesis and diseases associated with protein aggregation].
    Laskowska E
    Postepy Biochem; 2007; 53(1):19-26. PubMed ID: 17718384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Functions of Small Heat Shock Proteins (HSPB) in Hepatocellular Carcinoma.
    Yamada N; Matsushima-Nishiwaki R; Kobayashi K; Takahata S; Toyoda H; Kumada T; Kozawa O
    Curr Mol Med; 2021; 21(10):872-887. PubMed ID: 33563195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders.
    Carra S; Rusmini P; Crippa V; Giorgetti E; Boncoraglio A; Cristofani R; Naujock M; Meister M; Minoia M; Kampinga HH; Poletti A
    Philos Trans R Soc Lond B Biol Sci; 2013 May; 368(1617):20110409. PubMed ID: 23530259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small heat shock proteins, especially HspB4 and HspB5 are promising protectants in neurodegenerative diseases.
    Zhu Z; Reiser G
    Neurochem Int; 2018 May; 115():69-79. PubMed ID: 29425965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N terminus of the small heat shock protein HSPB7 drives its polyQ aggregation-suppressing activity.
    Wu D; Vonk JJ; Salles F; Vonk D; Haslbeck M; Melki R; Bergink S; Kampinga HH
    J Biol Chem; 2019 Jun; 294(25):9985-9994. PubMed ID: 31097540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Heat Shock Proteins and Human Neurodegenerative Diseases.
    Muranova LK; Ryzhavskaya AS; Sudnitsyna MV; Shatov VM; Gusev NB
    Biochemistry (Mosc); 2019 Nov; 84(11):1256-1267. PubMed ID: 31760916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small heat shock proteins, protein degradation and protein aggregation diseases.
    Vos MJ; Zijlstra MP; Carra S; Sibon OC; Kampinga HH
    Autophagy; 2011 Jan; 7(1):101-3. PubMed ID: 21045566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.
    Chopra G; Shabir S; Yousuf S; Kauts S; Bhat SA; Mir AH; Singh MP
    Mol Neurobiol; 2022 Dec; 59(12):7513-7540. PubMed ID: 36205914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSPA1A-independent suppression of PARK2 C289G protein aggregation by human small heat shock proteins.
    Minoia M; Grit C; Kampinga HH
    Mol Cell Biol; 2014 Oct; 34(19):3570-8. PubMed ID: 25022755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Heat Shock Proteins Collaborate with FAIM to Prevent Accumulation of Misfolded Protein Aggregates.
    Kaku H; Balaj AR; Rothstein TL
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
    Kalmar B; Lu CH; Greensmith L
    Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock proteins as potential targets for protective strategies in neurodegeneration.
    Kampinga HH; Bergink S
    Lancet Neurol; 2016 Jun; 15(7):748-759. PubMed ID: 27106072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.